Nick C. Fox

UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 391 publications

Interpreting evolving evidence in Alzheimer's disease: implications for dementia clinicians.

Interpreting evolving evidence in Alzheimer's disease: implications for dementia clinicians.

Journal: The British journal of psychiatry : the journal of mental science

Published: August 05, 2026

SWI versus T2*GRE for ARIA-H monitoring: a pragmatic perspective on adoption in clinical practice.

SWI versus T2*GRE for ARIA-H monitoring: a pragmatic perspective on adoption in clinical practice.

Journal: Neuroradiology

Published: May 21, 2026

Recent Cochrane review has serious flaws: A perspective of clinicians and researchers from around the world.

Recent Cochrane review has serious flaws: A perspective of clinicians and researchers from around the world.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: May 13, 2026

What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?

What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?

Journal: Neurology

Published: May 04, 2026

Alzheimer's disease immunotherapy and the amyloid hypothesis: when aggregation obscures interpretation.

Alzheimer's disease immunotherapy and the amyloid hypothesis: when aggregation obscures interpretation.

Journal: Lancet (London, England)

Published: April 20, 2026

Exome analysis of 22,319 individuals links extremely rare copy-number variants and 22q11.21 dosage to Alzheimer risk.

Exome analysis of 22,319 individuals links extremely rare copy-number variants and 22q11.21 dosage to Alzheimer risk.

Journal: American journal of human genetics

Published: April 20, 2026

Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimer's Disease.

Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimer's Disease.

Journal: medRxiv : the preprint server for health sciences

Published: April 10, 2026

Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.

Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.

Journal: medRxiv : the preprint server for health sciences

Published: April 10, 2026

Effect of Cognitive Reserve on Age at Symptom Onset and Cognitive Decline in Individuals With Dominantly Inherited Alzheimer Disease.

Effect of Cognitive Reserve on Age at Symptom Onset and Cognitive Decline in Individuals With Dominantly Inherited Alzheimer Disease.

Journal: Neurology

Published: April 08, 2026

Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.

Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: March 30, 2026

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 18, 2026

Comparing amyloid immunotherapy with cholinesterase inhibitors for Alzheimer's disease.

Comparing amyloid immunotherapy with cholinesterase inhibitors for Alzheimer's disease.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: March 16, 2026

Showing 1-12 of 391

Last Updated: 09/26/2026